SSUMY News Alert Sumitomo Corp Sp ADR (SSUMY) 12.6150 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sumitomo Corp Sp ADR (SSUMY) 12.6150 $SSUMY

GE Wins Alstom Board Approval; Govt Seeking 20% Stake - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 1:25PM CDT
General Electric (GE) won unanimous approval of the French conglomerate Alstom's board to acquire its energy assets in a $16.9 billion deal, taking it a step closer to clinching its biggest acquisition ever.

GE Improves Alstom Power Bid, Siemens Follows Suit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 2:30PM CDT
Pulling the ball back in its court, General Electric (GE) made a strong comeback to counter the Siemens-Mitsubishi offer for Alstom's energy assets by updating its offer to buy the French engineering group's energy assets.

United Tech Amends Canada Deal, Reaffirms Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:30PM CDT
United Technologies (UTX) declared that Sikorsky has amended a contract agreement with the Canadian Government. The amended contract will allow Canada to replace its maritime fleet with 28 Sikorsky's CH148 Cyclone helicopters.

GE, CTSI to Build Cancer Network in India - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 10:50AM CDT
GE Healthcare recently formed a strategic partnership with Cancer Treatment Services International to launch a chain of 25 cancer care centres in India.

Falling Earnings Estimates Signal Weakness Ahead for Raven (RAVN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 7:49AM CDT
It may be a good decision to sell Raven as its price dropped significantly in the past four weeks, the stock witnessed a negative trend in earnings estimate revisions and a poor Zacks Rank confirms weakness.

Raven Down to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 3:00PM CDT
Zacks Investment Research has downgraded Raven to a Zacks Rank #5 (Strong Sell).

3M's China Growth at Triple Pace - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 3:30PM CDT
3M recently projected that sales in China will triple in the next five years compared to the rest of the world, driven by a huge demand for health and consumer products such as face masks and water filters.

GE's 2Q Operating Earnings Marginally Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 19, 10:38AM CDT
General Electric reported relatively disappointing second quarter 2013 results with operating earnings of $3.7 billion or 36 cents a share compared to $4.0 billion or 38 cents a share in the year-ago quarter.


Japan gives Myanmar $504M loan, forgives debt
By AYE AYE WIN - AP - Sun May 26, 5:14AM CDT
YANGON, Myanmar (AP) — Japan's government on Sunday extended its first loan to Myanmar in 26 years and canceled the remainder of the Southeast Asian country's debt, as Tokyo looks to re-establish strong economic ties with the former pariah nation.


Abe on 1st trip to Myanmar by Japan PM in 36 years
By AYE AYE WIN - AP - Fri May 24, 8:49AM CDT
YANGON, Myanmar (AP) — Prime Minister Shinzo Abe arrived in Myanmar on Friday on the first visit to the country by a Japanese leader in 36 years, as Tokyo bids to reassert its position as a top economic partner after decades of frosty relations with the previous military regime.

Deal signed to clear Myanmar debt, allow new loans
By AYE AYE WIN - AP - Sun Jan 27, 9:56PM CST
YANGON, Myanmar (AP) — The World Bank announced a long-awaited deal to allow Myanmar to clear part of its huge decades-old foreign debt, opening the door for new much-needed lending to jumpstart its lagging economy.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 398

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading

Top 5 Most Recently Viewed Articles

Christina Lake Cannabis Moves to Revise Debenture Terms

Updated Category News Views 176

Christina Lake Cannabis Plans to Amend Debenture Agreements VANCOUVER, British Columbia – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) has announced a significant strategic initiative aimed at altering the terms of its convertible debentures, totaling an aggregate principal...

Continue Reading
Senseonics Secures $16 Million for CGM Expansion Efforts

Updated Category News Views 225

Significant Funding Announcement by Senseonics Senseonics Holdings (NYSE: SENS), a leader in medical technology focused on diabetes management, has announced an important agreement to boost its operations. Through a registered direct offering and a concurrent private placement, the company aims to raise approximately $16 million. This funding aligns with Senseonics'...

Continue Reading
XRP Mining: An Innovative Approach to Crypto Yield Generation

Updated Category News Views 144

Revolutionizing Cryptocurrency Mining with XRP As the cryptocurrency market continuously evolves at a rapid pace, traditional mining practices are being replaced by more intelligent and efficient methods. Among these, XRP Mining stands out as a groundbreaking approach that enables individuals to earn daily cryptocurrency income without needing costly hardware or intricate...

Continue Reading
Orgenesis Launches Trading on OTCQX Following Nasdaq Delisting

Updated Category News Views 94

Orgenesis Begins Trading on OTCQX Orgenesis Inc, a prominent player in the biotech sector dedicated to enhancing cell and gene therapies, has recently made a significant shift by commencing trading on the OTCQX Best Market under the ticker symbol "ORGS". This transition comes after the company faced delisting from the Nasdaq Stock Market due to not meeting the necessary...

Continue Reading
Investors Encouraged to Join Bath & Body Works Lawsuit

Updated Category News Views 178

Understanding the Bath & Body Works Class Action Lawsuit Bath & Body Works, Inc. (NYSE: BBWI) has come under scrutiny as a result of a class action lawsuit regarding securities fraud. This legal action comes on behalf of investors who purchased BBWI securities within a specific timeframe. If you fall under this category, you may have the opportunity to seek compensation...

Continue Reading